Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Recovery article

CJC-1295 Ipamorelin: Benefits, Dosage & DAC vs No-DAC

Evidence and status Approval status Not FDA approved Strongest support Limited human research Route context Human studies and reported practice; no approved route Competitive sport Prohibited in sport Lab work Animal studies Human studies Approved label CJC-12

Evidence and status

Approval status Not FDA approved

Strongest support Limited human research

Route context Human studies and reported practice; no approved route

Competitive sport Prohibited in sport

Lab work

Animal studies

Human studies

Approved label

CJC-1295 is studied for body composition, recovery, and sleep through growth hormone signaling. Its DAC, or Drug Affinity Complex, lets the peptide bind to albumin and remain active longer. The no-DAC version is shorter acting. Both are often paired with ipamorelin.

Get the Free Peptide Tracking Toolkit

CJC-1295 + many more

Explore the guide, then keep the details you verify in the Excel workbook.

Excel workbook

11 worksheets for vials, schedules, labs, storage, and more.

PDF guide

Review providers, products, documents, storage, and travel.

Get the free toolkit

Free download

Useful before or after you start

  • Before you start, compare the details that matter and build a focused question list.
  • Already using peptides? Keep vials, administration, sites, wellness notes, labs, storage, and travel together.
  • Separate your schedule from what actually happened, so important dates are easier to spot.
  • Keep your private working copy on your own device.

Confirm your email to receive both downloads and your personal 20% off coupon.

Almost done

We sent the first email to .

Confirm your email to get the toolkit and your 20% off coupon.

We also sent a verification text. Reply YES to confirm your phone number.

  1. 1

    Confirm your email

    Open the first email and click the confirmation link.

  2. 2

    Only after step 1

    Then the toolkit arrives

    We email your Excel workbook and PDF guide right away. Your personal 20% off coupon follows when ordering opens.

The first email should arrive within a minute. Do not see it? Check spam or promotions.

Tell us where to send it

Free, no spam, only peptide news that matters. Unsubscribe anytime.

What is CJC-1295?

CJC-1295 is a modified peptide based on the first 29 amino acids of growth-hormone-releasing hormone — the sequence that carries GHRH's biological activity.

The modifications make it more stable than natural GHRH, which is broken down in the body within minutes. By mimicking GHRH, CJC-1295 prompts the pituitary to secrete growth hormone in a natural, pulsatile pattern rather than flooding the body with synthetic GH.

DAC vs non-DAC (Mod GRF 1-29)

The single most important distinction with CJC-1295 is whether it carries DAC:

  • CJC-1295 with DAC. DAC (Drug Affinity Complex) binds to albumin in the bloodstream, which dramatically extends the peptide's half-life. The result is a sustained elevation of GH and IGF-1 over several days from a single dose, dosed roughly once or twice weekly.
  • CJC-1295 without DAC (Mod GRF 1-29). Without the DAC group, the peptide is short-acting — it clears within a few hours and produces a sharp, brief GH pulse. It is dosed more frequently, typically alongside a meal-timed protocol.

The form used in a protocol changes the dosing schedule and stack design. Confirm the exact form with the prescribing provider.

The naming can be confusing. CJC-1295 originally refers to the long-acting DAC compound. Products sold as “CJC-1295 no DAC” are generally Mod GRF 1-29, a related short-acting GHRH analog rather than the same molecule with one ingredient removed.

Benefits and uses

People use CJC-1295 for several goals connected with growth hormone and IGF-1:

  • Body composition. Users discuss CJC-1295 for lean-mass and fat-loss goals because it raises GH and IGF-1.
  • Recovery. People training hard report using it to support recovery between sessions.
  • Sleep. Growth hormone is released in the deepest stages of sleep; users report improved sleep quality on GHRH-analog protocols.
  • Healthy-aging goals. Interest comes from the age-related decline in GH and IGF-1 and from users tracking those levels over time.

A controlled study in healthy adults measured sustained increases in GH and IGF-1 after CJC-1295 with DAC. Most downstream body-composition, sleep, recovery, and healthy-aging outcomes come from reported use rather than large clinical trials.

The ipamorelin pairing

CJC-1295 is frequently paired with ipamorelin. The rationale combines two different growth-hormone signals.

CJC-1295 acts at the GHRH receptor, while ipamorelin acts at the ghrelin receptor. Clinics and users describe the pairing as a way to create a stronger pulse. Direct trials have not established the best combined regimen or its long-term outcomes.

The CJC-1295 and ipamorelin stack guide covers daily blend terminology, reported timing, reconstitution, and combined monitoring questions.

For a broader protocol, compare the stack with other muscle and performance peptides, and see sermorelin for the shorter-acting GHRH alternative.

How it works

CJC-1295 binds the GHRH receptor on the pituitary and stimulates the synthesis and release of growth hormone. The released GH acts on the liver and other tissues to produce IGF-1, the insulin-like growth factor that mediates most of GH's anabolic and repair effects.

Because the signal goes through the body's own pituitary, GH is released in pulses rather than as a constant synthetic level — the appeal over direct GH injection.

Biology and chemistry details

CJC-1295 is a synthetic analog of growth-hormone-releasing hormone (GHRH). It is based on the biologically active region of GHRH and modified to resist rapid breakdown, which is why it lasts longer than natural GHRH.

The DAC version uses a Drug Affinity Complex that binds albumin and extends half-life for a sustained GH and IGF-1 signal. The non-DAC version is commonly called Mod GRF 1-29; it produces a shorter GH pulse and is usually discussed separately from CJC-1295 with DAC.

Dosage and administration

CJC-1295 is given by subcutaneous injection. Dosing depends entirely on the form: the DAC version is dosed roughly once or twice weekly because of its extended half-life, while the non-DAC version (Mod GRF 1-29) is dosed more frequently, often before bed or post-workout, to align with natural GH pulses.

It is commonly combined with ipamorelin in a single injection. These are not official dosing guidelines — there is no FDA-approved CJC-1295 product — and dosing should be set by the prescribing provider.

Reconstitution and drawing the right volume on an insulin syringe is where most errors happen. Use the peptide dosage calculator to convert a prescribed target dose into syringe units for the vial size.

Side effects and safety

Users report injection-site reactions, flushing, headache, and water retention. Controlled studies also recorded transient injection-site reactions and flushing.

Because it raises GH and IGF-1, the relevant monitoring is for the effects of higher GH: blood sugar can rise, and IGF-1 should be kept within a sensible range rather than pushed indefinitely.

Long-term human safety data for CJC-1295 specifically is limited. Anyone using it should monitor IGF-1 and metabolic markers and work with a provider.

Legal status and how to get CJC-1295

CJC-1295 was not among the 12 peptides removed from the FDA's Section 503A Category 2 list in April 2026. The July advisory committee did not consider it. Its compounding status remains more constrained than the reclassified peptides.

If prescribed after evaluation by a licensed provider, CJC-1295 should come from an appropriate pharmacy. Products sold online "for research use only" are not approved, manufactured, or quality-controlled for human use, and buying them carries quality and legal risk.

Get the Free Peptide Tracking Toolkit

CJC-1295 + many more

Explore the guide, then keep the details you verify in the Excel workbook.

Excel workbook

11 worksheets for vials, schedules, labs, storage, and more.

PDF guide

Review providers, products, documents, storage, and travel.

Get the free toolkit

Free download

Useful before or after you start

  • Before you start, compare the details that matter and build a focused question list.
  • Already using peptides? Keep vials, administration, sites, wellness notes, labs, storage, and travel together.
  • Separate your schedule from what actually happened, so important dates are easier to spot.
  • Keep your private working copy on your own device.

Confirm your email to receive both downloads and your personal 20% off coupon.

Almost done

We sent the first email to .

Confirm your email to get the toolkit and your 20% off coupon.

We also sent a verification text. Reply YES to confirm your phone number.

  1. 1

    Confirm your email

    Open the first email and click the confirmation link.

  2. 2

    Only after step 1

    Then the toolkit arrives

    We email your Excel workbook and PDF guide right away. Your personal 20% off coupon follows when ordering opens.

The first email should arrive within a minute. Do not see it? Check spam or promotions.

Tell us where to send it

Free, no spam, only peptide news that matters. Unsubscribe anytime.

Blood work to track CJC-1295

CJC-1295 works by raising GH and IGF-1, so those are the direct readouts of whether it's doing anything:

  • IGF-1 — the primary marker for any GH-releasing peptide. It should rise if CJC-1295 is working and can help identify excessive GH exposure.
  • Human Growth Hormone — a direct GH measure that complements IGF-1.

Test at baseline and again at 4–8 weeks.

CJC-1295 and other growth-hormone-releasing factors are prohibited by WADA at all times.

Peptide Baseline Measurement Panel

Get your baseline

  • No doctor visit required
  • 2,200+ Quest locations
  • Results in 1–2 business days

Get your baseline

References

Banned in competitive sport. This peptide is prohibited by the World Anti-Doping Agency (WADA), and athletes subject to drug testing can face sanctions for using it. Check current WADA and league rules before considering it.

For general education only — not medical advice or a treatment recommendation. Peptides are not a substitute for care from a licensed provider. Talk to a qualified healthcare professional before you start, stop, or change any peptide, medication, or supplement.

CONNECTED / MODULES

Post-session references

Selected from shared article topics. Source links are retained where available.

01

Handling & safety lane

Source-derived education, not individual medical guidance or an instruction to dose.

PROCEDURE

How to Source CJC 1295 & Ipamorelin for Your Lab

Acquiring authentic peptides CJC 1295 and Ipamorelin for your San Francisco lab is a straightforward process built on trust and transparency. At Real Peptides, we've streamlined access to ensure you get the high-purity compounds you need without compromising quality. The key is to demand verification. Every vial of our CJC1295 Ipamorelin 5MG 5MG blend comes with a guarantee of at least 98% purity, confirmed by independent, third-party lab testing. This documentation is your assurance that you're working with a research tool of the highest caliber, free from contaminants that could skew your results. For San Francisco's dedicated researchers, we provide not just a product, but a reliable foundation for discovery, delivered with the professionalism your important work deserves. Your next breakthrough starts with materials you can trust implicitly. Find the Right Peptide Tools for Your Lab
SIDE EFFECTS

Side Effect Management

Each pathway's mechanism creates different side effect profiles that impact daily life differently. CJC-1295's gradual approach typically produces the mildest side effects. Some users experience mild water retention, but the sustained nature means your body adapts progressively. Ipamorelin's pulse-based approach can cause temporary hunger surges and mild lethargy post-injection, but these effects are predictable and time-limited. MK-677's ghrelin mimicry creates the most complex side effect profile. Increased appetite is nearly universal, water retention can be significant, and some users experience insulin sensitivity changes that require dietary adjustments.
02

Question drills

Open a question for its connected answer.

01What If the Research Model Involves Combining CJC 1295 No DAC With Other Peptides?+

Combination protocols are standard in GH research. The most common pairings involve CJC 1295 no DAC with growth hormone secretagogues (GHRPs like ipamorelin, GHRP-2, GHRP-6, or hexarelin) to achieve synergistic GH release. Administer both peptides simultaneously or within five minutes of each other—receptor activation must overlap temporally to suppress somatostatin and amplify the GH pulse. A secondary common combination involves CJC 1295 no DAC with BPC 157 Peptide or TB 500 Thymosin Beta 4 in tissue repair models studying whether GH-mediated anabolic signaling enhances collagen synthesis or wound healing rates. These peptides act on distinct receptor systems and can be reconstituted in the same syringe if administered immediately—do not pre-mix and store combined peptides, as interaction stability data does not exist for most combinations.

SOURCE / realpeptides.co ↗
02What If the Reconstituted Peptide Looks Cloudy or Has Visible Particles?+

Discard it immediately and do not use it in any experimental protocol. Cloudiness or particulate matter indicates protein aggregation or contamination. Both compromise biological activity and introduce confounding variables. Properly reconstituted CJC-1295 no DAC peptide should be clear and colorless. Aggregation occurs when reconstitution is performed incorrectly (shaking instead of gentle swirling, injecting bacteriostatic water too forcefully, using non-sterile water) or when the lyophilized powder was exposed to temperature excursions before reconstitution. Cloudy peptide solutions contain denatured or partially-degraded protein that won't bind GHRH receptors reliably.

SOURCE / realpeptides.co ↗
03What If Baseline IGF-1 Levels Are Already Elevated Before Starting CJC-1295 No DAC & Ipamorelin Administration?+

Elevated baseline IGF-1 (above 250 ng/mL in adult models) may blunt the observable GH response due to heightened negative feedback sensitivity. IGF-1 signals the hypothalamus to increase somatostatin release, which inhibits further GH secretion. This is the body's primary regulatory brake. In such cases, researchers might observe normal GH pulse initiation but shortened pulse duration or reduced amplitude. If studying GH secretagogue efficacy in aging or metabolic dysfunction models where IGF-1 is typically low, elevated baselines suggest the model organism doesn't reflect the target population. Consider stratifying subjects by baseline IGF-1 or incorporating a washout period if prior GH-modulating interventions were used.

SOURCE / realpeptides.co ↗
04What If the Peptides Were Left at Room Temperature for 24 Hours After Reconstitution?+

Peptide degradation at 20–25°C is time-dependent but significant. At 24 hours of ambient exposure, expect 15–30% loss of bioactivity for Ipamorelin and 20–40% for CJC-1295 no DAC. If this occurs once, the vial is not worthless but is compromised. Reduce expected efficacy proportionally or discard and reconstitute fresh. Prevention: store reconstituted vials in a dedicated medication refrigerator with temperature monitoring, not a shared kitchen fridge where door-opening causes frequent temperature cycling.

SOURCE / realpeptides.co ↗
03

Evidence cooldown

Research context and source excerpts for a slower second read.

RESEARCH

Why Top Researchers Choose CJC-1295 & Ipamorelin

In the competitive landscape of biotechnology and physiological research, having access to precise, reliable tools isn't just an advantage—it's a necessity. That's why forward-thinking labs and institutions are increasingly focusing on the powerful synergy of peptides CJC 1295 and Ipamorelin. This combination isn't just another compound; it's a strategic choice for studying the endocrine system with a level of specificity that was once difficult to achieve. The real magic lies in how these two peptides work together. CJC-1295 is a Growth Hormone Releasing Hormone (GHRH) analogue, while Ipamorelin is a selective Growth Hormone Releasing Peptide (GHRP) and ghrelin mimetic. Together, they stimulate the pituitary gland through two different pathways, creating a more potent and naturalistic pulse of growth hormone release in research subjects. This dual-action mechanism is what makes the blend a superior tool for investigations into cellular regeneration, metabolic function, and age-related physiological decline. For researchers in Oakland, the integrity of their materials directly impacts the validity of their data. At Real Peptides, we understand that deeply. Our commitment goes beyond simply selling products; we provide the foundational elements for discovery. What sets our CJC1295 Ipamorelin 5MG 5MG blend apart is our unwavering dedication to purity and verification. While other suppliers might offer products with questionable origins or incomplete documentation, we ensure every batch is subjected to rigorous third-party testing. This guarantees that what you receive is exactly what's on the label, free from contaminants and at the correct concentration. This meticulous process provides the consistency your experiments demand, eliminating variables that could compromise your findings. Researchers choose this specific peptide combination for its targeted action and favorable profile in studies. Unlike more aggressive compounds, Ipamorelin does not significantly impact other hormones like cortisol or prolactin, allowing for a cleaner data set when studying the effects of GH elevation. This makes the CJC-1295 and Ipamorelin stack particularly valuable for long-term studies where maintaining hormonal balance is critical. The research applications are incredibly broad, spanning several key areas of modern science: Metabolic Studies: Investigating its role in lipolysis and lean mass composition. Anti-Aging Research: Exploring effects on skin elasticity, cellular repair, and overall vitality in test models. Recovery and Repair: Studying its potential to accelerate tissue regeneration in muscle, connective tissue, and bone. Our dedication to advancing science doesn't stop with one product. We recognize that comprehensive research often requires a multi-faceted approach. That's why we also offer a range of related compounds, such as our potent Tesamorelin Ipamorelin Growth Hormone Stack for more advanced studies, or foundational peptides like Sermorelin. We empower the Oakland research community by being a one-stop source for high-quality tools, ensuring that your next breakthrough is built on a foundation of trust and purity. When you choose Real Peptides, you're not just buying a product; you're investing in the integrity of your work. Explore High-Purity Research Peptides

RESEARCH

CJC 1295 & Ipamorelin Washington | Research Peptide Source

For pioneering researchers in Washington, the quest for reliable compounds is paramount. The synergistic blend of peptides CJC 1295 and Ipamorelin offers a powerful tool for study, and Real Peptides is your trusted source for the highest purity compounds available for your 2026 projects.

05

Product & matchup locker

Linked catalog and comparison files.

Comparison

Comparison: GH Secretagogues vs. Direct T-Boosters

Let’s lay it out in a simple table to make the distinction crystal clear. Mechanism Stimulates pituitary to release Growth Hormone (GH) Stimulates hypothalamus to release GnRH, th…

Comparison

Mod GRF 1-29 vs. CJC-1295 with DAC: A Head-to-Head Comparison

To make this as clear as possible, our team put together a quick comparison. It’s not about which one is "better"—that's the wrong question. It's about which tool is appropriate f…

Comparison

Comparison: CJC-1295 No DAC vs. CJC-1295 with DAC

To further clarify the distinct CJC-1295 no DAC benefits, let's compare it directly with its DAC-modified counterpart. This table highlights the key differences that researchers m…